Insulin therapy in type 1 diabetes;L'insulinothérapie dans le diabète de type 1

Revue Medicale de Liege

Volumn 60, Issue 5-6, 2005, Pages 322-328

  Philips, Jean Christophe ^a,b   Radermecker, R P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Insulin analogues; Insulin therapy; Type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN; INSULIN GLARGINE;

BLOOD GLUCOSE MONITORING; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC BALANCE; POSTPRANDIAL STATE; QUALITY OF LIFE; REVIEW;

DIABETES MELLITUS, TYPE 1; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT EDUCATION; POSTPRANDIAL PERIOD;

EID: 21744450746     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Scheen AJ.- Essai de restauration de la boucle de régulation glucose-insuline chez le patient diabétique insulinodépendant. Rev Med Liège, 1992, 47, 373-383.
2. Lebrethon MC, Philippart D, Rocour-Brumioul D, et al.- Le diabète de l'enfant et de l'adolescent. 1. Prise en charge par le Service Universitaire de Pédiatrie et la Cellule «Education-Diabète» en Pediatric. Rev Med Liège, 2005, 60, 313-319.
3. Bourguignon J-P, Rocour-Brumioul D, Collard J, et al.- Le diabète de l'enfant et de l'adolescent: 2. Aspects particuliers chez l'adolescent. Rev Med Liège, 2005, 60, 320-321.
4. 1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. Diabetes Care, 1999, 22, 795-800.
5. Binder C, Lauritzen T, Faber O, et al.- Insulin pharmacokinetics. Diabetes Care, 1984, 7, 188-199.
6. Radermecker RP.- Le risque hypoglycémique: implications thérapeutiques. Rev Med Liège, 2005, 60, 461-465.
7. Radermecker RP, Hermans MP, Legrand DA, Scheen AJ.- L'insulinothé rapie par pompe externe à perfusion continue d'insuline. Rev Med Liège, 2005, 60, 329-334.
8. Hirsch IB.- Insulin analogues. New Engl J Med, 2005, 352, 174-183.
9. Philips J-C, Scheen AJ.- L'insulinothérapie dans le diabète de type 2. Rev Med Liège, 2005, 60, 419-423.
10. Anderson JH Jr, Brunelle RL, Koivisto VA, et al.- Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes, 1997, 46, 265-270.
11. Siebenhofer A, Plank J, Berghold A, et al.- Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. Diabetologia, 2004, 47, 1895-1905.
12. Nobels F, Scheen AJ.- Le rôle des centres de convention du diabète en Belgique. Rev Med Liège, 2005, 60, 619-623.
13. Scheen AJ.- Insuline glargine (Lantus,). Rev Med Liège, 2004, 59, 110-114.
14. Chapman TM, Perry CM.- Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus. Drugs, 2004, 64, 2577-2595.
15. The Diabetes Control and Complications Trial Research Group.- The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
16. Bott S, Bott U, Berger M, et al.- Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia, 1997, 40, 926-932.
17. Grimm J-J, Hegar K, Berger W.- L'insulinothérapie «fonctionnelle» chez le diabétique de type 1. In: Journées de Diabétologie de l'Hôtel-Dieu, Flammarion, Médecine-Sciences, Paris, 2000, 145-154.
18. DAFNE Study Group.- Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ, 2002, 325, 746-751.
19. Pieber TR, Brunner GA, Schnedl WJ, et al.- Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care, 1995, 18, 625-630.